2021
DOI: 10.21203/rs.3.rs-858010/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Satisfaction in Population-Based Cancer Screening in a Chinese Rural High-Risk Population: The Yangzhong Early Diagnosis and Treatment of Upper Gastrointestinal Cancer

Abstract: Background Screening for upper gastrointestinal cancer (UGC) effectively reduces morbidity and mortality in gastric and oesophageal cancers. It is considered one of the effective measures for cancer control in China, but studies on its functional quality are lacking. Our study assessed the quality of screening service funded by Upper Gastrointestinal Cancer Early diagnosis and treatment (UGCEDAT) and its correlation in Yangzhong People’s hospital, China. Methods A cross-sectional study was conducted among 51… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…Nevertheless, the two-stage ESCC screening strategy effectively identified more EC patients while saving resources. As the number of individuals undergoing opportunistic screening increases 27 , this strategy can also be applied to follow-up monitoring and management of those who undergo baseline EC screening. Despite the rapid development of liquid biopsy and multi-omics technologies, there are currently no recommended biomarkers for EC screening 28 .…”
Section: Ec Screening In Chinamentioning
confidence: 99%
“…Nevertheless, the two-stage ESCC screening strategy effectively identified more EC patients while saving resources. As the number of individuals undergoing opportunistic screening increases 27 , this strategy can also be applied to follow-up monitoring and management of those who undergo baseline EC screening. Despite the rapid development of liquid biopsy and multi-omics technologies, there are currently no recommended biomarkers for EC screening 28 .…”
Section: Ec Screening In Chinamentioning
confidence: 99%